Sunday, March 16, 2025

Creating liberating content

New Delhi: India and New Zealand decided to relaunch negotiations

BENGALURU: IBM chairman and CEO Arvind Krishna’s compensation rose 23%

Mumbai: A host of global and domestic factors are expected

Ranjani Srinivasan’s self-deportation became an advertisement for the newly launched

Related News

New Delhi: India and New Zealand decided to relaunch negotiations for a free trade agreement on Saturday after a gap of 10 years, a move aimed at deepening economic ties

BENGALURU: IBM chairman and CEO Arvind Krishna’s compensation rose 23% to $25 million in 2024 compared to $20.3 million he earned in the year-ago period, showed IBM’s 2025 proxy statement.

Mumbai: A host of global and domestic factors are expected to weigh on investors’ sentiment when Dalal Street opens for trading on Monday. The escalating global tariff war between the

Ranjani Srinivasan’s self-deportation became an advertisement for the newly launched CBP Home app. Secretary of Homeland Security Kristi Noem announced the launch of the CBP Home App on March 10

SRINAGAR: The decomposed bodies of two Kashmiri brothers reported missing since Feb 13 along with a third person were found three days apart in a river in J&K’s Kulgam district,

Pope Francis concelebrates Holy Mass in the chapel of the apartment on the tenth floor of the Gemelli hospital, where he continues his treatment, in Rome, Italy, on March 16,

Trending News

New Delhi: India and New Zealand decided to relaunch negotiations for a free trade agreement on Saturday after a gap of 10 years, a move aimed at deepening economic ties

Mumbai: A host of global and domestic factors are expected to weigh on investors’ sentiment when Dalal Street opens for trading on Monday. The escalating global tariff war between the

NEW DELHI: India’s foreign exchange reserves recorded their sharpest weekly gain in more than three years in the week ending 7 March. The exchange surged $15.27 billion to reach $653.97

MUMBAI: A special court rejected CBI’s chargesheet against Indiabulls Housing Finance Ltd (IHFL), share broker Sanjay Dangi, and DB Realty promoters (Shahid Balwa and Vinod Goenka) along with their associate

Gold prices have reached new record highs, but Gold ETFs experienced a notable slowdown in February, with monthly inflows dropping by 47.22% to Rs 1,979 crore, compared to Rs 3,751

India’s foreign exchange reserves saw a significant jump of USD 15.267 billion, reaching a total of USD 653.966 billion during the week ending March 7, marking the largest increase in

Popular Painkiller Shows Surprising Potential To Prevent Cancer Spread

Word Count: 402 | Estimated Reading Time: 3 minutes



In a surprising breakthrough, experts have found that a common painkiller, aspirin, could play a crucial role in preventing the spread of cancer. Researchers from the University of Cambridge discovered how aspirin may help in the fight against some types of cancer by potentially stopping them from metastasising. This groundbreaking finding could offer an affordable and accessible option in cancer treatment, as previous studies suggested that aspirin could enhance the immune system’s ability to target and eliminate harmful cancer cells. The team’s discovery marks a significant milestone in cancer research, offering hope for more effective treatment options in the future.

Dr Jie Yang, from the University of Cambridge, told The Metro that the discovery was ‘a Eureka moment’, as before this the scientists were not ‘aware of the implication of our findings in understanding the anti-metastatic activity of aspirin.’

According to a BBC report, aspirin disrupts the platelets and removes their influence over the T-cells so they can hunt out the cancer.

Prof Rahul Roychoudhuri, from the University of Cambridge, told BBC: “What we’ve discovered is that aspirin might work, surprisingly, by unleashing the power of the immune system to recognise and kill metastasising cancer cells.”

He thinks the drug would work best in cancers that have been caught early and could be used after treatment, such as surgery, to help the immune system find any cancer that might already have spread.

“If you are a cancer patient, don’t rush to your local pharmacy to buy aspirin just yet, but actively consider participation in ongoing or upcoming trials of aspirin,” says Prof Mangesh Thorat, a surgeon and cancer researcher at Queen Mary University of London, told the BBC.

He says the study provided “the missing piece of the jigsaw puzzle” in understanding how aspirin works, but there were still questions to answer.

But there is risk…

The BBC report suggests that aspirin can cause dangerous internal bleeding, including strokes, so the risks have to be balanced. It is also not clear whether the effect works for all cancers or just specific ones. And this is still animal research, so while the scientists think this would apply to people, that will still need to be confirmed.

Some patients – with Lynch syndrome, which increases the risk of cancers – are already recommended aspirin. But it will still take proper clinical trials to understand whether more patients would benefit too.




Source link

Most Popular Articles

Sign In

Welcome ! Log into Your Account